Knowthestock.com
CTEK - CynergisTek Inc

Sell

Weak GrowthEarnings/Profit is Negative

20%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 37.76%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative but improving
Net Margin is -46.01%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.59
Debt Ratio is 0.14
Current Debt to Net Income Ratio is 0.23
Total Debt to Total Assets Ratio is 0.02
Cash Flow is WEAK
Cash from Operations is Negative but improving
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
CynergisTek Inc (CTEK) - cynergistek.com
CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, and compliance goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS as a top performing firm in healthcare cybersecurity and was awarded the 2019 Top Healthcare Cybersecurity Consultants in Black Book IT Advisory Outcomes Survey.
Exchange - NYSE MKT LLC
Industry - Dental Laboratories
Sector - Manufacturing
CEO -
Employees - 107
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.